Loring Wolcott & Coolidge Fiduciary Advisors LLP Abbott Laboratories Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.3 Billion
- Q1 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,698,873 shares of ABT stock, worth $222 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
1,698,873
Previous 1,723,720
1.44%
Holding current value
$222 Million
Previous $195 Million
15.59%
% of portfolio
2.18%
Previous 1.79%
Shares
34 transactions
Others Institutions Holding ABT
# of Institutions
3,464Shares Held
1.34BCall Options Held
10.5MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$22.1 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.89 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.07 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...